Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/4/2019
SIETES contiene 92718 citas

 
 
 1 a 20 de 206 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol 2019;75:febrero. [Ref.ID 103013]
3. Cita con resumen
Costa CS, Bagatin E, Martimbianco ALC, da Silva EMK, Lúcio MM, Magin P, Riera R. Oral isotretinoin for acne. Cochrane Database of Systematic Reviews 2018:24 de noviembre. [Ref.ID 102889]
4.Enlace a cita original Cita con resumen
Tangamornsuksan W, Lohitnavy M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol 2018;154:1 de abril. [Ref.ID 102558]
5. Cita con resumen
Imatoh T, Sai K, Fukasawa C, Hinomura Y, Nakamura R, Okamoto-Uchida Y, Segawa K, Saito Y. Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database. Eur J Clin Pharmacol 2017;73:1643-53. [Ref.ID 102180]
6. Cita con resumen
Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy Is not necessarily forever. JAMA 2017;318:82-3. [Ref.ID 102053]
7. Cita con resumen
Walter SR, Day RO, Gallego B, Westbrook JI. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia. Br J Clin Pharmacol 2017;83:416-26. [Ref.ID 101933]
8. Cita con resumen
Finch A, Kubler P. The management of gout. Australian Prescriber 2016;39:1 de agosto. [Ref.ID 100572]
10.Tiene citas relacionadas Cita con resumen
Ko TM, Tsai CY, Chen S-Y, Chen KS, Yu K-H, Chu C-S, Huang CM, Wang CR, Weng C-T, Yu C-L, Hsieh S-C, Tsai J-C, Lai W-T, Tsai W-C, Yin G-D, Ou T-T, Cheng K-H, Yen J-H, Liou T-L, Lin T-H, Chen D-Y, Hsiao P-J, Chen DY, Weng M-Y, Chen Y-M, Chen C-H, Liu F-M, Yen H-W, Lee J-J, Hung S-Y, Luo S-F, Yang Y-H, Chuang H-P, Chou Y-C, Liao H-T, Wang C-W, Huang C-L, Chen P, Wong C-S, Wu J-Y, Chen Y-T, Shen C-Y, for the Taiwan Allopurinol-SCAR Consortium. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ 2015;351:h4848. [Ref.ID 99587]
11.Tiene citas relacionadas Cita con resumen
Li-Wan-Po A. Pharmacogenetics begins to deliver on its promises. BMJ 2015;351:h5042. [Ref.ID 99584]
12. Cita con resumen
Yang C-Y, Chen CH, Deng S-T, Huang C-S, Lin Y-J, Chen Y-J, Wu C-Y, Hung S-L, Chung W-H. Allopurinol use and risk of fatal hypersensitivity reactions: A nationwide population-based study in Taiwan. JAMA Intern Med 2015;175:1550-7. [Ref.ID 99256]
13. Cita con resumen
Anónimo. Galantamine: atteintes cutanées graves. Prescrire 2015;35:105. [Ref.ID 98914]
14. Cita con resumen
Anónimo. Levure de riz rouge: troubles musculaires et hépatiques. Prescrire 2015;35:18. [Ref.ID 98901]
15. Cita con resumen
Anónimo. Gliptines: pemphigoïdes bulleuses. Prescrire 2014;34:829. [Ref.ID 98462]
16. Cita con resumen
Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang -CH, Ho H-C, Chen MJ, Lin JY, Hui C-Y, Ho J-C, Wu W-M, Chen T-J, Wu T, Wu Y-R, Hsih M-S, Tu P-H, Chang C-N, Hsu C-N, Wu T-L, Choon S-E, Hsu C-K, Chen D-Y, Liu C-S, Lin C-Y, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang T-H, Chuang S-S, Tsai S-F, Chang C-J, Chang YS, Hung S-I, for the Taiwan Severe Cutaneous Adverse Reaction Consortium and the Japan Pharmacogenomics Data Science Consortium. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014;312:525-34. [Ref.ID 97851]
19. Cita con resumen
Anónimo. Tétrazépam: syndromes de Lyell et autres troubles graves. Prescrire 2013;33:268. [Ref.ID 95338]
Seleccionar todas
 
 1 a 20 de 206 siguiente >>